Croda International Plc

Croda International Plc

49GP.L
Croda International PlcGB flagLondon Stock Exchange
87.00
GBp
- -
- -
121.44MMarket Cap
Croda International Plc
49GP.L
(London Stock Exchange)

Recent

price

87.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
1,002
1,028
1,052
1,077
1,047
1,082
1,244
1,373
1,387
1,378
1,390
1,890
2,089
1,694
1,628
1,699
Sales/Revenue/Turnover
20.07
23.12
24.23
24.45
23.16
24.2
22.97
23.74
23.71
23.22
20.86
23.06
21.28
14.61
14.89
15.28
Operating Margin (%)
33
31
31
34
37
38
49
53
56
66
82
113
121
126
136
137
Depreciation Expense
131
168
151
178
165
181
197
237
238
224
202
321
649
171
158
62
Net Income, GAAP
32.5
31.54
31.1
28.87
27.99
28.22
28.33
24.64
25.02
25.97
25.19
21.56
16.24
27.17
23.2
28.9
Effective Tax Rate (%)
13.06
16.29
14.35
16.48
15.79
16.71
15.82
17.26
17.2
16.25
14.5
16.98
31.08
10.09
9.74
3.65
Profit Margin (%)
160
155
213
175
195
222
237
253
300
231
354
434
673
589
548
450
Working Capital
282
268
256
213
202
308
415
426
448
512
847
873
481
660
651
534
LT Debt
274
266
344
419
489
607
609
830
998
869
1,595
1,766
2,431
2,368
2,297
2,202
Total Equity
25.08
28.32
29.02
28.08
24
21.17
19.47
20.4
17.17
15.3
10.59
12.91
12.77
5.84
6.1
6.24
Return on Invested Capital (%)
34.39
41.02
46.81
69.7
68.75
58.94
48.66
53.87
27.53
17.59
13.82
17.78
30.8
8.08
7.6
3.39
Return on Capital (%)
147.3
116.81
190.9
1,267.86
1,180.71
1,290.71
1,405
1,692.86
56.69
28.7
25.35
32.97
47.24
10.31
9.52
3.81
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.62%
7.73%
-4.13%
Free Cash Flow
7.07%
1.09%
21.08%
Net Income, GAAP
3.36%
3.94%
-60.88%
Sales/Revenue/Turnover
5.47%
5.61%
4.38%
Total Cash Common Dividend
22.26%
6.09%
1.77%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,694
2024
- -
- -
- -
- -
1,628
2025
- -
- -
- -
- -
1,699

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Croda International Plc is a United Kingdom-based specialty chemicals company founded in 1925 and headquartered in Goole, England. It manufactures and supplies a broad range of performance ingredients and technologies that serve multiple industries globally, including personal care, pharmaceuticals, agriculture, nutrition, and industrial markets. Its main product categories include speciality chemicals such as oleochemicals, surfactants, specialty lipids (including omega-3 oils), pharmaceutical excipients, emulsifiers, crop protection ingredients, fragrance and flavor compounds, and industrial additives. These products are designed for use in formulations across consumer care (beauty care, personal care, home care, and fragrance), life sciences (pharmaceuticals, agriculture, and seed enhancement), and industrial specialties (coatings, textiles, fibers, water treatment, and food emulsifiers). Croda operates manufacturing sites, laboratories, and offices worldwide, including in Europe, North America, Asia, and South America. Recent major changes include a new organizational structure implemented in 2024 that makes the Consumer Care and Life Sciences divisions fully accountable for strategy and performance, enhancing operational efficiency with targeted annual cost savings of £9 million starting 2025. The company has accelerated innovation efforts, expanding the pipeline of new and protected products which accounted for 35% of total sales in 2024, up from 33% in 2023. It is completing an intensive investment cycle with two new greenfield manufacturing sites scheduled for commissioning in 2025 and pursuing a £40 million multi-year efficiency and modernization program to increase asset utilization, reduce costs, and drive margin recovery. Croda continues strategic integration of recent acquisitions such as Solus Biotech and prioritizes delivering returns from these investments to position for future earnings growth. Overall, Croda International Plc focuses on high-value specialty chemicals with a sustainability and innovation-driven approach, supplying globally diversified industries with advanced ingredient solutions that improve product performance and meet evolving market needs. It leverages smart science to enhance people's lives through safer, more effective, and sustainable chemical products across its three main sectors of Consumer Care, Life Sciences, and Industrial Specialties. This description reflects Croda's comprehensive product portfolio, global operations, and recent strategic developments to enhance growth and efficiencies as of 2025.